SHORT COURSE
Market Access in MedTech
Registration closes on 16 Feb 2024
Date: 26 Feb – 1 Mar 2024
Time: 9:00am – 6:00pm (SGT)
Format: Hybrid
Venue: Tahir Foundation Building
* there may be slight change in the date and timing
Course outline
- Are you interested in Market Access in Medical Devices, Diagnostics or Digital Health?
- Do you want to drive better patient access to these MedTech innovations?
- How are they so different from pharmaceuticals?
- Who will pay for them, and why?
If these questions crossed your mind, then this course is for you!
Key concepts will be shared, illustrated by case studies from leading MedTechs. The emphasis is less on the theory, more on the practical applications and real-life experience, at country/regional/global levels.
Learning outcomes
At the end of the course, participants will be able to:
- Navigate complex market access pathways, barriers and opportunities
- Develop a market access strategy, including reimbursement strategy and policy shaping
- Develop a robust value proposition and dossier
- Outline an evidence generation strategy, including real-world evidence (RWE) and health economics and outcomes research (HEOR)
- Value-based healthcare, pricing & procurement, and ecosystem shaping
Topics
- How to develop a Market Access Strategy for MedTech
- Overview of healthcare systems in APAC with deep dives into Australia, Japan, China & Korea
- HTA policies and evolution in APAC
- Precision Medicine: Market Access Strategy for Genomics
- Market Access Strategy for Niche Innovations
- Digital Health & Diagnostics
- What is a Value Dossier & how to localise it? Pitfalls & learnings from Middle East & Africa
- Value-based healthcare, value-based pricing & procurement
- Policy shaping & stakeholder engagement
- HTA submissions & evaluations
- Group case study (Market Access Strategy)
- Journey & career in Market Access
View full programme here.
Pre-requisites
- NIL
Course instructors
Click here to view instructors’ biographies
Anh Bourcet, PhD Market Access Head ex-Abbott and Johnson & Johnson | |
 | Nordin Charafi Director, Payer Partnerships & Market Access (AMEA) Illumina |
 | Alice Chu, PhD Senior Director, Market Access and Medical Affairs Glaukos Corporation (APAC) |
 | Arif Fahim Director Asia-Pacific, Health Economics & Reimbursement Abbott Medical Devices |
 | Laura Goldstein Senior Director, Global & US Health Economics & Market Access Johnson & Johnson |
 | Tomas Hatem Senior Manager, Strategic investment and Impact Division The Global Fund |
 | Sungwon Jung, PhD Director, Government Affairs & Market Access Baxter Korea |
 | Jamie Kebely Vice President, Government Affairs (APJ) Siemens Healthineers |
 | Sang-Soo Lee, PhD Senior Director for Government, Affairs and Market Access (GAMA) Medtronic North Asia |
 | Michael Nobes, PhD Director, Asia Pacific Market Access Abbott Diabetes Care |
 | Harry Peng Market Access & Public Policy Associate Manager Roche Diagnostics Taiwan |
 | Edmund Shi, PhD Head of China Health Economics and Market Access Johnson & Johnson MedTech |
 | Yot Teerawattananon, PhD Co-Director, Medical Innovation Development and Assessment Support (MIDAS) Visiting Professor, Saw Swee Hock School of Public Health (SSHSPH) |
 | Lavni Varyani Founding Partner Pharma Business Partners |
 | Wee Hwee Lin, PhD Associate Professor Saw Swee Hock School of Public Health (SSHSPH) |
Click here to view instructors’ biographies
Course Fees*
| Category | Fees inclusive of GST (SGD) |
| Students/LMIC1 | $1,438.80 |
| Partners2/NUS staff | $2,398.00 |
| Public sector/NGOs | $3,597.00 |
| Private sector | $5,995.00 |
- The LMIC definition will act according to the list of countries belonging to the low- and lower-middle income economies as listed by the World Bank. The corresponding fee will apply to individuals and organisations belonging to the LMIC.
- Partners refer to staff under the NUHS cluster (including NUH, NTFGH, AH, JCH, NUP, National University Cancer Institute Singapore, National University Heart Centre Singapore, National University Centre for Oral Health Singapore, Centre for Innovation in Healthcare), HTAsiaLink & iDSI members.
- Public sector refers to any government agency, hospital or state university.
- Private sector refers to any private hospital, university or private company.
* Prices stated above are in Singapore Dollars (SGD) and are inclusive of 9% Singapore Goods and Services Tax (GST).
** The University reserves the right to review and adjust the course fees and make changes to the programme structure and requirements as necessary and accordingly without prior notice.
Certification
An electronic Certificate of Participation will be awarded to participants who meet a minimum of 75% attendance.
Cancellation Policy
- Any cancellation must be conveyed to the course administrator in writing via email.
- A cancellation charge of 50% of the fee will be levied if the cancellation is received before 4 February 2024.
- No refunds will be given from 4 February 2024 onwards but replacement with another name is permissible.
- The school reserves the right to cancel the course due to low enrolment or unforeseen circumstances. If the course is cancelled, the School will refund the course fees paid in full.
Registration
Please scan the below QR code for registration or click here.
Registration closes on 16th February, 2024.
For more information on this course, please contact us at sshsphevents@nus.edu.sg